Allison Wills 2022-04-14 Allison Wills 2022-04-14 Better Value, Better Health 20-03 Read More Allison Wills 2022-04-14 Allison Wills 2022-04-14 A Balancing Act: How Private Payers Are Meeting the Needs of Specialty Medicine 20-02 Read More Allison Wills 2022-01-24 Allison Wills 2022-01-24 By the Numbers: Healthcare in Canada, Before and After Covid 19-01 Read More Allison Wills 2022-01-22 Allison Wills 2022-01-22 Covid the Change-Maker: Lessons for Specialty Healthcare 19-02 Read More Allison Wills 2022-01-22 Allison Wills 2022-01-22 Interview: Raising the Access Bar 19-03 Read More Allison Wills 2021-10-18 Allison Wills 2021-10-18 By the Numbers: Oncology in Canada 18-01 Read More Allison Wills 2021-10-18 Allison Wills 2021-10-18 Oncology in Canada: A Landscape in Perpetual Motion 18-02 Read More Allison Wills 2021-10-18 Allison Wills 2021-10-18 Bringing Oncology Treatment Down to Earth 18-03 Read More Allison Wills 2021-07-17 Allison Wills 2021-07-17 By the Numbers: Rare Diseases and Conditions 17-01 Read More Allison Wills 2021-07-15 Allison Wills 2021-07-15 Rare Disease Update: Status, Strides, Setbacks 17-02 Read More Allison Wills 2021-07-14 Allison Wills 2021-07-14 Champion of Change 17-03 Read More Allison Wills 2021-07-14 Allison Wills 2021-07-14 Advocating Out Loud 17-04 Read More Allison Wills 2021-04-22 Allison Wills 2021-04-22 By the Numbers: Outcomes-based Agreements 16-01 Read More Allison Wills 2021-04-21 Allison Wills 2021-04-21 Outcomes-Based Agreements in Canada: An Overview 16-02 Read More Allison Wills 2021-04-20 Allison Wills 2021-04-20 Frameworks for Outcomes-Based Agreements 16-03 Read More Allison Wills 2021-04-19 Allison Wills 2021-04-19 Data for Outcomes-Based Agreements 16-04 Read More Allison Wills 2021-04-18 Allison Wills 2021-04-18 Dr. Luca Pani: The Italian OBA Connection 16-05 Read More Allison Wills 2021-01-21 Allison Wills 2021-01-21 By the Numbers: Originator Biologics and Biosimilars Come Out on Top 15-01 Read More Allison Wills 2021-01-20 Allison Wills 2021-01-20 Tug of War: Biosimilars And Biologics Have Yet to Settle into Harmonious Coexistence 15-02 Read More Allison Wills 2021-01-19 Allison Wills 2021-01-19 Biosimilar Breakthrough: Alan Low on the Impact of B.C.’s Biosimilar Policies 15-03 Read More Newer Posts Older Posts
Allison Wills 2022-04-14 Allison Wills 2022-04-14 A Balancing Act: How Private Payers Are Meeting the Needs of Specialty Medicine 20-02 Read More
Allison Wills 2022-01-24 Allison Wills 2022-01-24 By the Numbers: Healthcare in Canada, Before and After Covid 19-01 Read More
Allison Wills 2022-01-22 Allison Wills 2022-01-22 Covid the Change-Maker: Lessons for Specialty Healthcare 19-02 Read More
Allison Wills 2021-10-18 Allison Wills 2021-10-18 Oncology in Canada: A Landscape in Perpetual Motion 18-02 Read More
Allison Wills 2021-10-18 Allison Wills 2021-10-18 Bringing Oncology Treatment Down to Earth 18-03 Read More
Allison Wills 2021-07-17 Allison Wills 2021-07-17 By the Numbers: Rare Diseases and Conditions 17-01 Read More
Allison Wills 2021-07-15 Allison Wills 2021-07-15 Rare Disease Update: Status, Strides, Setbacks 17-02 Read More
Allison Wills 2021-04-22 Allison Wills 2021-04-22 By the Numbers: Outcomes-based Agreements 16-01 Read More
Allison Wills 2021-04-21 Allison Wills 2021-04-21 Outcomes-Based Agreements in Canada: An Overview 16-02 Read More
Allison Wills 2021-04-20 Allison Wills 2021-04-20 Frameworks for Outcomes-Based Agreements 16-03 Read More
Allison Wills 2021-04-18 Allison Wills 2021-04-18 Dr. Luca Pani: The Italian OBA Connection 16-05 Read More
Allison Wills 2021-01-21 Allison Wills 2021-01-21 By the Numbers: Originator Biologics and Biosimilars Come Out on Top 15-01 Read More
Allison Wills 2021-01-20 Allison Wills 2021-01-20 Tug of War: Biosimilars And Biologics Have Yet to Settle into Harmonious Coexistence 15-02 Read More
Allison Wills 2021-01-19 Allison Wills 2021-01-19 Biosimilar Breakthrough: Alan Low on the Impact of B.C.’s Biosimilar Policies 15-03 Read More
